{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/589245621",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1327154972"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#589245621",
  "code": "2A90.A",
  "source": "http://id.who.int/icd/entity/589245621",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/589245621/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Anaplastic large cell lymphoma, ALK-positive"
  },
  "definition": {
    "@language": "en",
    "@value": "A T-cell peripheral lymphoma composed of usually large, pleomorphic, CD30 positive T-lymphocytes with abundant cytoplasm characterised by the presence of a translocation involving the ALK gene and expression of ALK fusion protein. Most patients present with peripheral and/or abdominal lymphadenopathy, and often have advanced disease and extranodal involvement."
  },
  "inclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "Anaplastic large cell lymphoma, CD30-positive"
      }
    }
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Anaplastic large cell lymphoma, ALK-positive"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Anaplastic large cell lymphoma, CD30-positive"
      }
    }
  ]
}